March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
Retinal Navigated Laser (Navilas®) Compared Versus Conventional Laser In Diabetic Macular Edema
Author Affiliations & Notes
  • Marcus Kernt
    Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Munich, Germany
  • Igor Kozak
    Ophthalmology, University of California San Diego, La Jolla, California
  • Florian Seidensticker
    Ophthalmology, Ludwig-Maximilians- University, Munich, Germany
  • Aljoscha S. Neubauer
    Ophthalmology, Ludwig-Maximilians University, Ottobrunn, Germany
  • Armin Wolf
    Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Munich, Germany
  • Michael W. Ulbig
    Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Munich, Germany
  • William R. Freeman
    Ophthalmology, UCSD Jacobs Retina Center, La Jolla, California
  • Anselm Kampik
    Dept of Ophthalmology, University of Munich LMU, Munich, Germany
  • Footnotes
    Commercial Relationships  Marcus Kernt, Alcon, Allergan, OD-OS, Optos (C); Igor Kozak, None; Florian Seidensticker, None; Aljoscha S. Neubauer, AstraZeneca, Bristol-Myers Squibb, OD-OS (C); Armin Wolf, None; Michael W. Ulbig, None; William R. Freeman, OD-OS (C); Anselm Kampik, Allergan, Novartis, OD-OS (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 384. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Marcus Kernt, Igor Kozak, Florian Seidensticker, Aljoscha S. Neubauer, Armin Wolf, Michael W. Ulbig, William R. Freeman, Anselm Kampik; Retinal Navigated Laser (Navilas®) Compared Versus Conventional Laser In Diabetic Macular Edema. Invest. Ophthalmol. Vis. Sci. 2012;53(14):384.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To compare clinical outcomes and re-treatment rates for a novel navigated laser (Navilas) versus conventional laser in the treatment of clinically significant macular edema (CSME).

Methods: : Focal laser for diabetic macular edema (DME) in 38 patients was digitally planned on fundus images and performed utilizing retina navigation with the Navilas® system (OD-OS GmbH, Teltow, Germany). Up to one year clinical follow-up of the case series at two sites investigated number of re-treatments and visual acuity. For a control group propensity score matching (nearest neighbour method) was performed based on of the chart review of 113 patients treated by conventional retina laser at the same institutions during the same time period.

Results: : In total, 79% of laser spots were visible on color images, of which 96% were within 100 µm from the planned target. In the unmatched complete group, the number of laser spots performed per patient with Navilas was 105+/-94; significantly (p<0.001) higher than with conventional laser (43+/-36). Before matching, follow-up available for Navilas patients was significantly shorter than for conventional patients (median 6.8 versus 13.5 months, p<0.001). Propensity score matching of Navilas patients with the conventional laser group for age, gender, baseline visual acuity, number of laser spots and follow-up time yielded 22 matched patients from the control group. Visual acuity at baseline was 0.50 +/- 0.37 LogMAR for Navilas and 0.35 +/- 0.38 LogMAR for conventional laser and remained stable (+/- 3 lines) in all patients after 3 and 6 months. The laser retreatment rate using Kaplan-Meier analysis showed separation of the curves after 2 months with less retreatments in Navilas group over the first 8 months. Given limited follow-up time this difference did not reach statistical significance.

Conclusions: : When performing navigated laser treatment (Navilas) for diabetic macular edema, significantly more laser spots were placed compared to conventional laser. This may be due to the ability to pre-plan and efficiently execute the treatment with the Navilas device. While longer follow-up times are required, the tendency for lower retreatment rates with Navilas may be an important factor when considering possible combination laser and anti-VEGF drug therapy.

Keywords: diabetic retinopathy • laser • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.